A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...

Medically reviewed by Steffini Stalos, DO Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the hollow organ in your abdomen that stores urine. The bladder has several ...

The current and future research in bladder cancer includes new single agents ... The increasing understanding of the tumor biology of TCC leads research in the study of VEGF and EGFR pathways.

Two main methods have been proposed in relation to bladder ART, as described in the ... Squamous cell carcinoma; TCC: Transitional cell carcinoma. † 3-year overall survival.

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring. Late detection often requires major surgeries such as ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...

A new study has identified a protein that helps drive bladder cancer by triggering the synthesis of cholesterol via mouse and cell models. Researchers found that a combination therapy of two drugs ...

A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs – gemcitabine and ...

SINGAPORE – A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs ...

Jan. 16, 2025 – Women under the age of 65 are more likely than men to be diagnosed with cancer, according to new data from the American Cancer Society. The risk is particularly stark for ...